Amgen INC (AMGN) Shareholder Gradient Investments LLC Trimmed Holding by $7.40 Million

James Marshall
January 14, 2018

Silvercrest Asset Management Group Llc sold 24,965 shares as the company's stock declined 2.08% while stock markets rallied. The firm earned $5.97 billion during the quarter, compared to analyst estimates of $5.75 billion. The stock decreased 0.61% or $1.12 during the last trading session, reaching $181.74. The company's stock had a trading volume of 3,082,770 shares, compared to its average volume of 2,720,000. Amgen Inc. (NASDAQ:AMGN) has risen 5.27% since January 13, 2017 and is uptrending. It has underperformed by 34.90% the S&P500. (AMGN) by 1881.73% based on its latest 2017Q3 regulatory filing with the SEC. Amgen, Inc. The stock has a market cap of $134,320.00, a price-to-earnings ratio of 16.72, a PEG ratio of 2.60 and a beta of 1.36.

On Friday, Shares of Amgen Inc.

Capital Investment Advisors Llc, which manages about $1.46 billion US Long portfolio, upped its stake in Abbvie (NYSE:ABBV) by 7,257 shares to 32,587 shares, valued at $2.90 million in 2017Q3, according to the filing. VelocityShares Daily Inverse VIX ST ETN (NASDAQ:XIV) has risen 166.34% since January 13, 2017 and is uptrending. (NASDAQ:AMGN). Murphy Pohlad Asset Mngmt Limited reported 1,378 shares or 0.18% of all its holdings.

Investors sentiment increased to 2.07 in Q3 2017. Its down 0.16, from 1.15 in 2017Q2. Capital Investors holds 0.85% or 4.62 million shares. Morgan Stanley has 8.71 million shares. Pointstate Lp reported 580,100 shares. Mason Street Advisors Llc reported 101,292 shares stake. The Texas-based King Luther Mgmt has invested 0.98% in Amgen Inc. (NASDAQ:AMGN). 36,764 were reported by Gamble Jones Counsel. Rafferty Asset Limited Com has 0.03% invested in Amgen Inc. Waverton Investment Management Ltd now owns 12,504 shares of the medical research company's stock valued at $1,902,000 after buying an additional 510 shares during the period. Lombard Odier Asset Mngmt (Usa) Corporation reported 500,000 shares. Barrow Hanley Mewhinney Strauss Lc invested in 0.13% or 573,292 shares. Meeder Asset Management reported 186 shares stake. Torray Ltd reported 0.1% stake. State Board Of Administration Of Florida Retirement System reported 0% stake. (NASDAQ:AMGN) for 401 shares. Therefore 0 are positive. Ignyta had 20 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with "Hold" on Monday, June 12. On Friday, July 21 the stock rating was maintained by Oppenheimer with "Buy". RBC Capital Markets maintained the stock with "Outperform" rating in Friday, July 31 report. Jefferies downgraded Ignyta, Inc. On Thursday, November 10 the stock rating was initiated by HSBC with "Buy". The firm has "Buy" rating by Mizuho given on Sunday, October 29. The firm has "Neutral" rating given on Wednesday, July 26 by UBS.

Perhaps, that suggests something about why 0.37% of the outstanding share supply is held by institutional investors. Its down 0.16, from 1.15 in 2017Q2.

A number of institutional investors and hedge funds have recently bought and sold shares of AMGN. 108 funds opened positions while 453 raised stakes. That value represents a market adjusting for revenues that have been falling by -0.65 % on a quarterly year/year basis as of the company's last quarterly report. Wendell David holds 12,300 shares. Cornerstone has 51,302 shares for 1.67% of their portfolio. Prentiss Smith And holds 0.68% or 7,275 shares. Reynders Mcveigh Cap Mgmt Ltd holds 10,304 shares. Walter Keenan Fincl Consulting Mi Adv holds 0.73% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 116,089 shares. Nomura Hldg holds 0.24% or 728,671 shares in its portfolio. Dixon Hubard Feinour Brown Va invested in 35,027 shares. Investors of record on Wednesday, February 15th will be paid a $1.15 dividend. (NYSE:BRO) for 4,200 shares. Broadleaf Partners LLC purchased a new stake in shares of Amgen during the fourth quarter worth about $2,429,000. (NASDAQ:MFSF). Denali has invested 0% in MutualFirst Financial, Inc. 6,231 are owned by Wms Partners Limited Liability Com. Merriman Wealth Management Llc owns 147,189 shares or 6.52% of their USA portfolio. 8,300 are owned by Legg Mason Asset (Japan).

What Historical Figures Say About Amgen Inc. One analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and ten have given a buy rating to the company's stock. Therefore 100% are positive. Finally, Bank of America lifted their target price on shares of Amgen to $210.00 and gave the stock a "buy" rating in a report on Thursday, October 5th. Vetr cut Amgen from a "buy" rating to a "hold" rating and set a $168.89 target price on the a research report on Monday. The rating was upgraded by Piper Jaffray to "Overweight" on Thursday, November 5. Mizuho reaffirmed a "buy" rating and set a $198.00 target price (up previously from $183.00) on shares of Amgen in a research note on Thursday, September 28th. Oppenheimer initiated Amgen Inc. Finally, BidaskClub raised shares of Amgen from a "strong sell" rating to a "sell" rating in a report on Saturday, December 2nd. (NASDAQ:AMGN) has "Overweight" rating given on Tuesday, December 15 by Morgan Stanley. BMO Capital Markets has "Buy" rating and $19900 target. (AMGN) has made a move of +3.41% over the past month, which has come on weak relative transaction volume.

The company's consensus rating on Reuter's scale remained unchanged from 2.5 to 2.5 during a month. The company was maintained on Friday, September 8 by Credit Suisse. Cowen & Co has "Market Perform" rating and $125.0 target. The firm has "Overweight" rating given on Friday, December 18 by Atlantic Securities.

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 8th. It also increased its holding in Vanguard Intl Equity Index Fds Msci Europe Etf (VGK) by 17,350 shares in the quarter, for a total of 91,164 shares, and has risen its stake in Microsoft Corp (NASDAQ:MSFT). (NASDAQ:AMGN). Aspiriant Limited Co owns 4,315 shares for 0.07% of their portfolio. They expect $3.02 earnings per share, up 4.50% or $0.13 from last year's $2.89 per share. BRO's profit will be $58.55M for 31.20 P/E if the $0.42 EPS becomes a reality. BMO Capital Markets restated a "hold" rating and set a $199.00 target price on shares of Amgen in a research report on Monday, September 25th.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article